GENE ONLINE|News &
Opinion
Blog

2021-08-17| M&A

Booming Bioanalytical CRO Sets Sights on Australian Market with 360biolabs Acquisition

by Rajaneesh K. Gopinath
Share To
After establishing its footprint in the west, Durham-based BioAgilytix Labs is looking to broaden its presence on the other side of the world. On August 16th, the leading global contract research laboratory announced plans to buy Australian CRO 360biolabs for an undisclosed amount.

BioAgilytix is currently operating in two US locations; Durham, North Carolina, and Boston, Massachusetts. Besides, it also has a laboratory in Hamburg, Germany. With the latest acquisition of 360biolabs, the company aims to extend its services to customers in Melbourne, Victoria.

GO Prime with only $1.49 now

LATEST
Targeting Metabolism for Noninvasive Multi-Cancer Early Detection Tests
2022-12-08
Moderna’s Personalized Cancer Therapy: The New Transformative Approach to Oncology
2022-12-08
SK Biopharmaceuticals' Partner Angelini Pharma Launches Cenobamate in France
2022-12-08
Relmada Blames ‘Implausible Placebo Results’ on Depression Drug’s Failure Again
2022-12-07
Using Sound Waves to Sort Blood-Based Nanoparticles
2022-12-07
Summit Bets $5 Billion On Akeso’s Bispecific Antibody
2022-12-07
Pharming announces publication of data from Phase 3 Study of leniolisib in patients with APDS in ASH's Blood
2022-12-07
EVENT
2022-12-10
64TH ASH ANNUAL MEETING & EXPOSITION
New Orleans, USA
2022-12-14
BIOHK2022
Hong Kong, China
2022-12-21
Avatar Medicine Forum
Online
2023-01-07
7th Asia Microbiome Conference
Taipei, Taiwan
2023-01-09
JPM Annual Healthcare Meeting 2023
San Francisco, USA
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!